Leveraging genetic correlations to prioritize drug groups for repurposing in type 2 diabetes

No abstract is available for this paper.

• Publication year

  2025

• Venue

  The Pharmacogenomics Journal

• Publication date

  2025-06-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41397-025-00392-zPMID 41224746
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A versatile data repository for GWAS summary statistics-based downstream genomic analysis of human complex traits

  2025cited by this paper
• Enhanced genetic fine mapping accuracy with Bayesian Linear Regression models in diverse genetic architectures

  2025cited by this paper
• Genetic drivers of heterogeneity in type 2 diabetes pathophysiology

  2024cited by this paper
• Evaluation of Bayesian Linear Regression derived gene set test methods

  2024cited by this paper
• Evaluation of Bayesian Linear Regression models for gene set prioritization in complex diseases

  2024influential reference
• The NHGRI-EBI GWAS Catalog: standards for reusability, sustainability and diversity

  2024cited by this paper
• The NHGRI-EBI GWAS Catalog: standards for reusability, sustainability and diversity

  2024cited by this paper
• Correction: Ethics approval and consent to participate

  2023cited by this paper
• DGIdb 5.0: rebuilding the drug–gene interaction database for precision medicine and drug discovery platforms

  2023cited by this paper
• Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

  2023cited by this paper
• A genetically supported drug repurposing pipeline for diabetes treatment using electronic health records

  2022cited by this paper
• Comparison of Rates of Type 2 Diabetes in Adults and Children Treated With Anticonvulsant Mood Stabilizers

  2022cited by this paper
• Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension

  2022cited by this paper
• Editorial: Genetic Pleiotropy in Complex Traits and Diseases

  2022cited by this paper
• Using Mendelian randomisation to identify opportunities for type 2 diabetes prevention by repurposing medications used for lipid management

  2022cited by this paper
• The effect of allopurinol on cardiovascular outcomes in patients with type 2 diabetes: a systematic review

  2022cited by this paper
• Expanded utility of the R package, qgg, with applications within genomic medicine

  2022influential reference
• Multi-Trait Genomic Risk Stratification for Type 2 Diabetes

  2021cited by this paper
• Integrative Network-Based Analysis Reveals Gene Networks and Novel Drug Repositioning Candidates for Alzheimer Disease

  2021cited by this paper
• Vascular Complications

  2021cited by this paper
• Treatment of type 2 diabetes: challenges, hopes, and anticipated successes.

  2021cited by this paper
• The power of genetic diversity in genome-wide association studies of lipids

  2021cited by this paper
• Gene-Based Analysis Reveals Sex-Specific Genetic Risk Factors of COPD

  2021cited by this paper
• Diseases 2.0: a weekly updated database of disease–gene associations from text mining and data integration

  2021cited by this paper
• A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives

  2021cited by this paper
• Effects of Uric Acid-Lowering Treatment on Glycemia: A Systematic Review and Meta-Analysis

  2020cited by this paper
• Integration of the Drug–Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts

  2020cited by this paper
• Biochemistry and Molecular Cell Biology of Diabetic Complications

  2020cited by this paper
• Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications

  2019cited by this paper
• Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval

  2019cited by this paper
• Genetic overlap of chronic obstructive pulmonary disease and cardiovascular disease-related traits: a large-scale genome-wide cross-trait analysis

  2019cited by this paper
• Turning genome-wide association study findings into opportunities for drug repositioning

  2019cited by this paper
• A catalog of genetic loci associated with kidney function from analyses of a million individuals

  2019cited by this paper
• Heritability of Type 2 Diabetes in the Washington State Twin Registry

  2019cited by this paper
• Carbamazepine-induced hyperglycemia: A rare case report

  2019cited by this paper
• Carbamazepine, a beta-cell protecting drug, reduces type 1 diabetes incidence in NOD mice

  2018cited by this paper
• Tumor Necrosis Factor‐Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus

  2018cited by this paper
• Gene set analysis methods: a systematic comparison

  2018cited by this paper
• Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits

  2018cited by this paper
• Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry

  2018cited by this paper
• Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps

  2018cited by this paper
• The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives

  2018cited by this paper
• qgg: an R package for large-scale quantitative genetic analyses

  2018cited by this paper
• A tutorial on conducting genome‐wide association studies: Quality control and statistical analysis

  2018cited by this paper
• Carbamazepine, a beta-cell protecting drug, reduces type 1 diabetes incidence in NOD mice

  2018cited by this paper
• Genomic Prediction from Multiple-Trait Bayesian Regression Methods Using Mixture Priors

  2018cited by this paper
• Likelihood Bayesian And Mcmc Methods In Quantitative Genetics

  2016cited by this paper
• The statistical properties of gene-set analysis

  2016cited by this paper
• Proteasome inhibitors, including curcumin, improve pancreatic β-cell function and insulin sensitivity in diabetic mice

  2016cited by this paper
• Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricemia: 3‐year randomized parallel‐controlled study

  2015cited by this paper
• A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease

  2015cited by this paper
• A global reference for human genetic variation

  2015cited by this paper
• Inhibition of MEK1 Signaling Pathway in the Liver Ameliorates Insulin Resistance

  2015cited by this paper
• The Concordance and Heritability of Type 2 Diabetes in 34,166 Twin Pairs From International Twin Registers: The Discordant Twin (DISCOTWIN) Consortium

  2015cited by this paper
• Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia

  2015cited by this paper
• The support of human genetic evidence for approved drug indications

  2015cited by this paper
• LD Score regression distinguishes confounding from polygenicity in genome-wide association studies

  2014cited by this paper
• Revisiting PPARγ as a target for the treatment of metabolic disorders

  2014cited by this paper
• Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study

  2014cited by this paper
• Diabetes and gout: efficacy and safety of febuxostat and allopurinol

  2013cited by this paper
• Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?

  2012cited by this paper
• Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study

  2011cited by this paper
• The contrasting roles of PPARδ and PPARγ in regulating the metabolic switch between oxidation and storage of fats in white adipose tissue

  2011cited by this paper
• "Likelihood, Bayesian, and Mcmc Methods in Quantitative Genetics"

  2010cited by this paper
• A versatile gene-based test for genome-wide association studies.

  2010cited by this paper
• Genomewide association studies and assessment of the risk of disease.

  2010cited by this paper
• Competing interests

  2010cited by this paper
• Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes

  2010cited by this paper
• Antidiabetic Action of Bezafibrate in a Large Observational Database

  2009cited by this paper
• Enrichment or depletion of a GO category within a class of genes: which test?

  2007cited by this paper
• The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes

  2007cited by this paper
• Thiazolidinedione-associated congestive heart failure and pulmonary edema.

  2004cited by this paper
• Thiazolidinedione-associated congestive heart failure and pulmonary edema.

  2003cited by this paper
• Bezafibrate reduces blood glucose in type 2 diabetes mellitus.

  2000cited by this paper
• Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease.

  2000cited by this paper
• Saddlepoint approximations for distributions of quadratic forms in normal variables

  1999cited by this paper
• Side effects from increased doses of carbamazepine on neuropsychological and posturographic parameters of humans.

  1997cited by this paper
• Correspondence and requests for materials should be addressed to M.L.L. (email:

  year unknowncited by this paper

• No citing papers are available for this paper.